1Perou CM,Sorlie T,Eisen MB. Molecular portraits of human breast tumours[J].Nature,2000,(6797):747-752.
2Sorlie T,Perou CM,Tibshirani R. Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications[J].Proceedings of the National Academy of Sciences(USA),2001,(19):10869-10874.
3Carey LA,Perou CM,Livasy CA. Race,breast cancer subtypes,and survival in the Carolina Breast Cancer Study[J].Journal of the American Medical Association,2006,(26):2492-2502.
4Cleator S,Heller W,Coombes RC. Triple-negative breast cancer:therapeutic options[J].Lancet Oncology,2007,(03):235-244.
5Rakha EA,El-Rehim DA,Paish C. Basal phenotype identifies a poor prognostic subgroup of breast cancer of clinical importance[J].European Journal of Cancer,2006,(18):3149-3156.
6Nielsen TO,Hsu FD,Jensen K. Immunohistochemical and clinical characterization of the basal-like subtype of invasive breast carcinoma[J].Clinical Cancer Research,2004,(16):5367-5374.doi:10.1158/1078-0432.CCR-04-0220.
7Sorlie T,Tibshirani R,Parker J. Repeated observation of breast tumor subtypes in independent gene expression data sets[J].Proceedings of the National Academy of Sciences(USA),2003,(14):8418-8423.doi:10.1073/pnas.0932692100.
8Rakha EA,El-Sayed ME,Green AR. Prognostic markers in triple-negative breast cancer[J].Cancer,2007,(01):25-32.doi:10.1002/cncr.22381.
9Siziopikou KP,Cobleigh M. The basal subtype of breast carcinomas may represent the group of breast tumors that could benefit from EGFR-targeted therapies[J].Breast,2007,(01):104-107.
10Livasy CA,Karaca G,Nanda R. Phenotypic evaluation of the basal-like subtype of invasive breast carcinoma[J].Modern Pathology,2006,(02):264-271.doi:10.1038/modpathol.3800528.
